Dr. Reddy’s Laboratories announced the launch of Metoprolol Succinate Extended-Release (ER) Tablets, the generic version of AstraZeneca‘s Toprol XL.

Metoprolol Succinate is a second generation cardioselective β-blocker indicated in the treatment of hypertension; stable, symptomatic (NYHA Class II or III) ischemic, hypertensive; cardiomyopathic heart failure; and long-term management of angina. β-blockers decrease cardiac rate, force of contraction and output, and renin secretion.

Metoprolol Succinate ER is available in 25mg, 50mg, 100mg, and 200mg dosage strength tablets in 100- and 500-count bottles.

For more information call or visit www.drreddys.com.